Form 8-K - Current report:
SEC Accession No. 0001628280-25-017612
Filing Date
2025-04-14
Accepted
2025-04-14 08:17:28
Documents
13
Period of Report
2025-04-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cccc-20250414.htm   iXBRL 8-K 24568
  Complete submission text file 0001628280-25-017612.txt   150960

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20250414.xsd EX-101.SCH 1829
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20250414_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20250414_pre.xml EX-101.PRE 13088
15 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20250414_htm.xml XML 2915
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 25834266
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)